Corporación Geo, S.A.B. de C.V. (GEOB.MX) develops, constructs, and sells affordable social interest housing communities targeting low- and middle-income segments in Mexico. Through its subsidiaries, the company engages in land acquisition, permitting, urban infrastructure development including schools, sports areas, commercial centers, and health facilities, design, marketing, and delivery of entry-level homes under the Casas GEO brand. It operates in 52 cities across 16 states, supported by government programs such as INFONAVIT and FOVISSSTE, positioning it as one of Mexico's most geographically diversified homebuilders in the industrial construction sector focused on residential properties.
Founded in 1981 and headquartered at Chicontepec 63, Hipodromo Condesa, Mexico City, the company listed on the Mexican Stock Exchange (BMV) in 1994. Its core offerings center on vivienda de interés social (social interest housing), sustainable communities with complete urban equipment, and medium-segment homes, with a business model emphasizing cost-effective development in dynamic urban areas.
In recent years, Corporación Geo underwent a major financial restructuring in 2014, involving over $4.5 billion in debt through a pre-packaged bankruptcy proceeding under Mexico's Ley de Concursos Mercantiles, resulting in significant equity dilution for existing shareholders and creditor control. The company announced partnerships, such as with Prudential Real Estate Investors (PREI) and Sólida for land investments and urban developments to optimize working capital and accelerate cash flow generation. Amid industry shifts toward urban densification and sustainable housing policies since 2012, GEO has adapted its strategy to higher-density projects near urban centers, aligning with government incentives from CONAVI and reduced emphasis on remote suburban developments. As of 2024-2025, the firm maintains a low-profile operational presence post-restructuring, with no major new funding rounds, acquisitions, or product launches publicly reported in the last 1-2 years.